Please login to the form below

Not currently logged in
Email:
Password:

Roche's Dr Hagen Pfundner elected chairman of VFA

German pharmaceutical industry association also appoints Pfizer's Dr Andreas Penk as deputy chairman

Roche's Dr Hagen Pfundner has been elected chairman of the German pharmaceutical industry association, the Verband Forschender Arzneimittelhersteller (VFA).

He succeeds Bayer's Dr Wolfgang Plischke and will serve alongside Dr Andreas Penk from Pfizer, who was confirmed as deputy chairman.

Dr Pfundner is the CEO of Roche Pharma AG, Germany and managing director of Roche Holding GmbH Germany.

One of Dr Pfundner's first tasks at the VFA will be to push for further changes to the reforms outlined last year for AMNOG – Germany's system for pharmaceutical pricing and reimbursement.

He said some “urgently necessary” amendments to the reforms were needed, including the introduction of a “benefit assessment” mechanism.

9th December 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...